Microbix Launches First Recombinant SARS-CoV-2 Antigen for QAPs and Test Makers

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

Microbix Biosystems Inc.: Microbix Commercializes SARS-CoV-2 Recombinant Antigen For Usage in QAPs and Test Manufacturing

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix), a life sciences innovator, manufacturer, and exporter, announces the commercial usage ...
BioWorld

Roche gains US EUA for SARS-CoV-2, influenza, RSV molecular test

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
Pharmabiz

WHO prequalifies the first two rapid antigen detection tests for Covid-19

WHO prequalifies the first two rapid antigen detection tests for Covid-19: Geneva Saturday, December 27, 2025, 11:00 Hrs [IST] The World Health Organization (WHO) announced the pr ...